Skip to content

Clinical trials

Phase 2 Mesothelioma, Malignant trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Mesothelioma, Malignant Phase: Phase 2 Clear all

120 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20005
20015
20023
20033
20044
20054
20066
20076
20083
20095
20105
20112
20122
20135
20141
20156
20166
20175
20183
20193
20203
20216
20226
20235
20246
20253
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed67
Unknown status16
Terminated14
Recruiting9
Active, not recruiting7
Withdrawn4
Not yet recruiting2
Suspended1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Cancer Institute (NCI)15
Alliance for Clinical Trials in Oncology5
European Organisation for Research and Treatment of Cancer - EORTC5
Memorial Sloan Kettering Cancer Center4
Swiss Cancer Institute4
M.D. Anderson Cancer Center3
The Netherlands Cancer Institute3
AGC Biologics S.p.A.2
Ain Shams University2
Azienda Ospedaliera Universitaria Senese2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Mesothelioma, Malignant120
Mesothelioma21
Solitary Fibrous Tumor, Pleural20
Carcinoma, Non-Small-Cell Lung8
Small Cell Lung Carcinoma6
Lung Neoplasms5
Sarcoma4
Carcinoma, Hepatocellular3
Colorectal Neoplasms3
Neoplasms3

Trials

Showing 76 to 100 of 120. Each trial links to its page on Pharma Observatory.

20 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.